Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma

ConclusionsSerum AKR1B10 is a new prognostic marker of HCC, better than AFP.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research